| Code | Description | Claims | Beneficiaries | Total Paid |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,033 |
1,033 |
$150K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,234 |
1,205 |
$136K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,265 |
1,229 |
$64K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
781 |
771 |
$61K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
494 |
494 |
$47K |
| 87428 |
|
709 |
703 |
$21K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
260 |
258 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
535 |
531 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
122 |
120 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
198 |
194 |
$6K |
| 87430 |
|
254 |
251 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
80 |
78 |
$3K |
| 99051 |
|
185 |
183 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
13 |
13 |
$1K |
| 87400 |
|
82 |
82 |
$1K |
| 87807 |
|
38 |
38 |
$442.70 |